Human Papillomavirus Vaccination of Boys and Extended Catch-up Vaccination: Effects on the Resilience of Programs (Q39278938)

10 September 2017

Human Papillomavirus Vaccination of Boys and Extended Catch-up Vaccination: Effects on the Resilience of Programs (English)

1 reference

10 September 2017

Silvia Franceschi

3

0 references

Joakim Dillner

series ordinal

4

object named as

Joakim Dillner

1 reference

10 September 2017

K Miriam Elfström

1

1 reference

10 September 2017

Fulvio Lazzarato

series ordinal

2

1 reference

10 September 2017

Iacopo Baussano

series ordinal

5

1 reference

10 September 2017

language of work or name

English

0 references

publication date

3 July 2015

1 reference

Journal of Infectious Diseases

10 September 2017

1 reference

10 September 2017

213

1 reference

10 September 2017

2

1 reference

10 September 2017

199-205

1 reference

Mitigation strategies for pandemic influenza in the United States.

10 September 2017

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIV368

Optimal vaccine allocation for the early mitigation of pandemic influenza

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIV368

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIV368

Measles still spreads in Europe: who is responsible for the failure to vaccinate?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIV368

Tuberculosis in New York City--turning the tide

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIV368

Tuberculosis control in New York City--a changing landscape

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIV368

Economic evaluation of influenza pandemic mitigation strategies in the United States using a stochastic microsimulation transmission model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIV368

Quadrivalent human papillomavirus vaccine effectiveness: a Swedish national cohort study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIV368

Type-specific human papillomavirus biological features: validated model-based estimates

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIV368

Upscaling human papillomavirus vaccination in high-income countries: impact assessment based on transmission model

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIV368

High-throughput monitoring of human papillomavirus type distribution

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIV368

Clustering of multiple human papillomavirus infections in women from a population-based study in Guanacaste, Costa Rica

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIV368

Clinical trials of human papillomavirus vaccines and beyond

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIV368

Efficacy of quadrivalent HPV vaccine against HPV Infection and disease in males

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIV368

A 9-Valent HPV Vaccine against Infection and Intraepithelial Neoplasia in Women

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIV368

Prevalence of human papillomavirus (HPV) types in cervical cancer 2003-2008 in Stockholm, Sweden, before public HPV vaccination.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIV368

Sex-specific immunization for sexually transmitted infections such as human papillomavirus: insights from mathematical models

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIV368

Seroepidemiology as basis for design of a human papillomavirus vaccination program.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIV368

Change in population prevalences of human papillomavirus after initiation of vaccination: the high-throughput HPV monitoring study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIV368

Cross-protective efficacy of two human papillomavirus vaccines: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIV368

Human papillomavirus and cervical cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIV368

UK committee recommends HPV vaccination for MSM.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIV368

Incidence and clearance of genital human papillomavirus infection in men (HIM): a cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIV368

Concurrent Infection with Multiple Human Papillomavirus Types: Pooled Analysis of the IARC HPV Prevalence Surveys

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIV368

Concurrent infections with multiple human papillomavirus (HPV) types in the New Technologies for Cervical Cancer (NTCC) screening study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIV368

21 January 2018

Identifiers

DOI

10.1093/INFDIS/JIV368

1 reference

10 September 2017

1 reference